Enterofit Oral Suspension contains Bacillus clausii spores (2 billion per dose), a probiotic formulation designed to restore and maintain the natural balance of intestinal microflora. Bacillus clausii is a non-pathogenic, spore-forming bacterium that exhibits resistance to gastric acidity and bile salts, enabling it to survive passage through the gastrointestinal tract and colonize the gut effectively. Enterofit is indicated for the prevention and adjunctive treatment of diarrhea of various etiologies, including antibiotic-associated diarrhea, infectious diarrhea, and other conditions resulting in dysbiosis. The suspension aids in re-establishing the physiological intestinal flora, thereby improving gut health and enhancing immune response. It is particularly beneficial in patients undergoing antibiotic therapy, as it helps mitigate the disruption of normal microbial flora caused by antimicrobial agents. Enterofit is well-tolerated with a favorable safety profile and can be administered to adults and children. The recommended dosage and duration of treatment should be followed as per medical advice. This probiotic suspension is a valuable therapeutic option for managing gastrointestinal disturbances and supporting overall digestive health.